salk vaccine
C1Formal, Historical, Scientific/Medical
Definition
Meaning
The first successful inactivated (killed) vaccine against poliomyelitis, developed by Jonas Salk.
Often used metonymically to refer to the successful scientific achievement of a preventative medical breakthrough against a major public health threat, or to vaccination campaigns of the mid-20th century.
Linguistics
Semantic Notes
Proper noun. Capitalized as it derives from a surname. Primarily refers to the specific historical vaccine and the event of its introduction. In contemporary context, often appears in historical, public health, or scientific writing rather than general medical advice (where "polio vaccine" is more common).
Dialectal Variation
British vs American Usage
Differences
No significant differences in meaning or usage. Both varieties treat it as a proper noun.
Connotations
Connotes a landmark achievement in medical science and a pivotal moment in 20th-century public health history in both cultures.
Frequency
Similar, very low frequency in both, restricted to specific historical or technical contexts.
Vocabulary
Collocations
Grammar
Valency Patterns
The Salk vaccine [VERB e.g., 'was introduced', 'prevented', 'used'][Proper Noun] developed the Salk vaccine.The public welcomed the Salk vaccine.Vocabulary
Synonyms
Strong
Neutral
Weak
Vocabulary
Antonyms
Usage
Context Usage
Business
Rare. Might appear in case studies on innovation, product development, or public-private partnerships in healthcare.
Academic
Used in history of medicine, public health, virology, and science & technology studies texts.
Everyday
Very rare. Might be used by older generations recalling the 1950s or in discussions about vaccine history.
Technical
Used in medical history, virology, and epidemiology to specify the vaccine type and distinguish it from later oral (Sabin) vaccines.
Examples
By Part of Speech
adjective
British English
- The Salk-vaccine era saw a dramatic drop in polio cases.
- It was a Salk-vaccine moment for public health.
American English
- It was a Salk vaccine breakthrough.
- The Salk vaccine campaign was a massive effort.
Examples
By CEFR Level
- The Salk vaccine helped to stop polio.
- Jonas Salk made an important vaccine.
- The introduction of the Salk vaccine in 1955 was a major public health victory.
- Unlike later oral vaccines, the Salk vaccine used an inactivated virus.
- The success of the Salk vaccine field trials in 1954 led to one of the largest public health mobilization efforts in US history.
- Historians often contrast the Salk (inactivated) and Sabin (live attenuated) vaccines in terms of their development, administration, and safety profiles.
Learning
Memory Aids
Mnemonic
Salk STOPPED polio. Think: Salk = Stopped (with a killed vaccine).
Conceptual Metaphor
MEDICAL BREAKTHROUGH IS A WEAPON/SHIELD ("the Salk vaccine shielded a generation"), SCIENTIFIC PROGRESS IS A LANDMARK ("a Salk vaccine moment").
Watch out
Common Pitfalls
Translation Traps (for Russian speakers)
- Avoid direct Cyrillic transliteration "Салк вакцина". The established Russian term is "вакцина Солка" (vaccine Salk-genitive).
- Do not confuse with "прививка от полиомиелита" (polio shot) which is generic; Salk vaccine is the specific historical one.
Common Mistakes
- Incorrect capitalization: "salk vaccine".
- Using it to refer to contemporary polio vaccines given to children.
- Confusing it with the later oral (Sabin) vaccine.
Practice
Quiz
What was a key characteristic of the Salk vaccine?
FAQ
Frequently Asked Questions
The original Salk vaccine formula is not. However, modern inactivated polio vaccines (IPV) are descended from it and are part of standard childhood immunization schedules in many countries.
The Salk vaccine is an inactivated (killed) virus injection. The Sabin vaccine is a live attenuated (weakened) virus given orally. Sabin's offered easier administration and better gut immunity but carried a tiny risk of causing vaccine-derived polio.
It was the first effective vaccine against polio, a dreaded disease that caused paralysis and death, primarily in children. Its success in the 1950s galvanized public trust in science and vaccination, dramatically reducing polio cases.
While Jonas Salk led the team that developed the vaccine at the University of Pittsburgh, the work built upon research by many others. The large-scale field trial was a massive collaborative effort involving the National Foundation for Infantile Paralysis and thousands of health workers.